- Home
- CDXS vs LTRX Comparison
CDXS vs LTRX Comparison
Compare CDXS & LTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDXS
- LTRX
- Stock Information
- Founded
- CDXS 2002
- LTRX 1989
- Country
- CDXS United States
- LTRX United States
- Employees
- CDXS N/A
- LTRX N/A
- Industry
- CDXS Major Chemicals
- LTRX Computer Communications Equipment
- Sector
- CDXS Industrials
- LTRX Telecommunications
- Exchange
- CDXS Nasdaq
- LTRX Nasdaq
- Market Cap
- CDXS 216.6M
- LTRX 197.5M
- IPO Year
- CDXS 2010
- LTRX 2000
- Fundamental
- Price
- CDXS $2.65
- LTRX $4.69
- Analyst Decision
- CDXS Buy
- LTRX Strong Buy
- Analyst Count
- CDXS 2
- LTRX 4
- Target Price
- CDXS $11.00
- LTRX $4.63
- AVG Volume (30 Days)
- CDXS 542.5K
- LTRX 455.7K
- Earning Date
- CDXS 10-30-2025
- LTRX 11-06-2025
- Dividend Yield
- CDXS N/A
- LTRX N/A
- EPS Growth
- CDXS N/A
- LTRX N/A
- EPS
- CDXS N/A
- LTRX N/A
- Revenue
- CDXS $57,164,000.00
- LTRX $122,923,000.00
- Revenue This Year
- CDXS $12.88
- LTRX $4.77
- Revenue Next Year
- CDXS $21.64
- LTRX $11.90
- P/E Ratio
- CDXS N/A
- LTRX N/A
- Revenue Growth
- CDXS N/A
- LTRX N/A
- 52 Week Low
- CDXS $1.90
- LTRX $1.91
- 52 Week High
- CDXS $6.08
- LTRX $5.72
- Technical
- Relative Strength Index (RSI)
- CDXS 55.26
- LTRX 47.81
- Support Level
- CDXS $2.46
- LTRX $4.85
- Resistance Level
- CDXS $2.76
- LTRX $5.46
- Average True Range (ATR)
- CDXS 0.16
- LTRX 0.38
- MACD
- CDXS 0.02
- LTRX -0.06
- Stochastic Oscillator
- CDXS 50.97
- LTRX 20.02
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
About LTRX Lantronix Inc.
Lantronix Inc is a networking company. It provides secure data access and management solutions for the Internet of Things (IoT) and information technology assets. It organizes its products and solutions into three product lines: Embedded IoT Solutions, IoT Systems Solutions, and Software and Services. The IoT System Solutions segment is the key revenue driver for the company. The company serves a diverse range of markets including healthcare, industrial, security, energy, transportation, and government networking. Its primary geographic markets are the Americas, Europe, the Middle East and Africa, and Asia Pacific Japan. The Americas contribute the vast majority of total revenue.